Belgium· BE-AMP-SAM211127-00
Puregon 300 IU/0.36 ml
A follitropin beta product containing human follitropin beta, recombinant, registered in Belgium by Organon. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Follitropin beta is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA06 (follitropin beta), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Follitropin beta · ATC G03GA06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Human Follitropin Beta, Recombinant
- Manufacturer
- Organon
- Country
- Belgium (BE)
- ATC code
- G03GA06
- ATC class
- Follitropin beta
- Defined daily dose
- 75 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
1 priced- be_apb1540020EUR 97.09
- be_apb0781294
- be_apb7737406
- be_apb4682043
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropin beta in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPUREGONN.V. Organon, Oss
- SpainPUREGON 300 UI/0,36 ML SOLUCION INYECTABLEOrganon N.V.
- FinlandFertavidMerck Sharp & Dohme B.V.
- SwedenPuregon 150 IE/0,18 ml Injektionsvätska, lösning i cylinderampullNV Organon
- IrelandPuregon 150 IU/0.18 mL Solution for injectionN.V. Organon
- United KingdomPuregon 100units/0.5ml solution for injection vialsWaymade Healthcare Plc
- IcelandPuregonN.V. Organon*
- PolandPuregonN.V. Organon
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Puregon
- Liechtenstein · Puregon
- Norway · Puregon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec8b51ca-3082-422e-a696-ff485b73c638 GET /v1/drugs/ec8b51ca-3082-422e-a696-ff485b73c638?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Puregon 300 IU/0.36 ml",
"name_fr": "Puregon 300 IU/0.36 ml",
"name_nl": "Puregon 300 IU/0.36 ml",
"amp_code": "SAM211127-00",
"strengths": [
"833.0000",
"1.0000"
],
"pack_count": 2,
"substances": [
"Human Follitropin Beta, Recombinant",
"Benzyl Alcohol",
"Sodium Hydroxide",
"Sucrose",
"Polysorbate 20",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Follitropin Beta",
"authorisation_numbers": [
"EU/1/96/008/038"
]
}See everything about follitropin beta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.